Overexpression of GSK-3β in Adult Tet-OFF GSK-3β Transgenic Mice, and Not During Embryonic or Postnatal Development, Induces Tau Phosphorylation, Neurodegeneration and Learning Deficits
GSK-3β or tau-kinase I is particularly abundant in the central nervous system (CNS), playing a key role in the pathogenesis of Alzheimer’s disease (AD). Accordingly, transgenic mouse models overexpressing this kinase recapitulate some aspects of this disease, such as tau hyperphosphorylation, neuron...
Main Authors: | Alberto Rodríguez-Matellán, Jesús Avila, Félix Hernández |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnmol.2020.561470/full |
Similar Items
-
GSK-3β, a pivotal kinase in Alzheimer disease
by: Maria eLLorens-Martin, et al.
Published: (2014-05-01) -
GSK-3 and Tau: A Key Duet in Alzheimer’s Disease
by: Carmen Laura Sayas, et al.
Published: (2021-03-01) -
GSK3β and Tau Protein in Alzheimer’s Disease and Epilepsy
by: Danira Toral-Rios, et al.
Published: (2020-03-01) -
Phosphorylation of protein Tau by GSK3β prolongs survival of bigenic Tau.P301L × GSK3β mice by delaying brainstem tauopathy
by: Natalia Crespo-Biel, et al.
Published: (2014-07-01) -
GSK3β-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions
by: Huazhang Zhu, et al.
Published: (2018-11-01)